Promega

Promega Corporation and FUJIFILM Cellular Dynamics Announce Strategic Collaboration to Advance Novel Assay Development

Retrieved on: 
星期四, 三月 10, 2022
Human body, Industry, Government, Senior, Commercial Operating System (COS), Drug development, Research, Cell, Potency (pharmacology), Movement, Quality of life, CDMO, Health, DNA, GLOBE, Technology, Patient, Fujifilm, Solution, Knowledge, Drug discovery, Disease, IPSC, RNA, Cell biology, Protein, Mobile phone, Pharmaceutical industry, Promega

MADISON, Wis., March 10, 2022 (GLOBE NEWSWIRE) -- Promega Corporation (Promega), a leader in providing innovative solutions andtechnical supportto the life sciences industry, and FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cell (iPSC) technologies, today announced a strategic collaboration to advance novel assay development for drug discovery.

Key Points: 
  • MADISON, Wis., March 10, 2022 (GLOBE NEWSWIRE) -- Promega Corporation (Promega), a leader in providing innovative solutions andtechnical supportto the life sciences industry, and FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cell (iPSC) technologies, today announced a strategic collaboration to advance novel assay development for drug discovery.
  • The agreement grants FUJIFILM Cellular Dynamics access to Promega Firefly Luciferase, NanoLuc Luciferase and NanoBiT Technology.
  • FUJIFILM Cellular Dynamics also licensed HaloTag Technology, a platform designed for functional characterization of proteins, under a previous agreement with Promega.
  • For its partners, FUJIFILM Cellular Dynamics, Inc. utilizes its iPSC platform to advance the progress of therapeutic candidates in the clinic and provides contract development and manufacturing (CDMO) services.

New Study Validates Novel Markers for Detecting Microsatellite Instability in Multiple Cancers

Retrieved on: 
星期四, 二月 3, 2022
Research, Other Health, Radiology, Pharmaceutical, Oncology, Medical Devices, Genetics, Clinical Trials, Science, Biotechnology, Medical Supplies, FDA, Health, DNA, Prostate, Government, Gold, Cancer, PCR, IVD, Technology, Microsatellite instability, Research, The Journal of Molecular Diagnostics, Partnership, Johns Hopkins, LMR, Johns Hopkins University, Cell biology, Drug development, Industry, FDA, MSI, Multimedia, Colorectal cancer, RNA, Medical imaging, Pharmaceutical industry, Casino, Promega, Journal

The study, published in the February issue of Journal of Molecular Diagnostics , is the first to use the PCR-based Promega LMR MSI Analysis System to detect MSI in endometrial, prostate and other cancers.

Key Points: 
  • The study, published in the February issue of Journal of Molecular Diagnostics , is the first to use the PCR-based Promega LMR MSI Analysis System to detect MSI in endometrial, prostate and other cancers.
  • The assay amplifies a panel of five mononucleotide repeat markers, each composed of 21-27 repeated adenine bases.
  • The LMR MSI Analysis System, launched in February 2021, consists of eight markers four of the gold standard markers, plus four novel LMR markers that have 52-60 repeated adenine bases each.
  • These results are encouraging for the detection of microsatellite instability in samples that were previously difficult or impossible.

Promega Earns a 2022 Top Workplaces USA Award

Retrieved on: 
星期二, 二月 1, 2022
Biotechnology, Other Health, Health, Pharmaceutical, Medical Supplies, Culture, DNA, Government, Engineering, Biotechnology, Research, COVID-19, Corporation, COVID-19 testing, Marketing, Trial balance, Cell biology, Drug development, Industry, Multimedia, RNA, Information technology, Management, Pharmaceutical industry, Risk management, Promega

Promega Corporation was recognized today as a top place to work in the US with a 2022 Top Workplaces USA award.

Key Points: 
  • Promega Corporation was recognized today as a top place to work in the US with a 2022 Top Workplaces USA award.
  • Companies earn a place on the Top Workplaces USA list based solely on employee engagement surveys compiled by research firm Energage.
  • View the full release here: https://www.businesswire.com/news/home/20220201006152/en/
    Promega is a winner of a 2022 Top Workplaces USA award, ranking in the top 50 among companies its size.
  • Companies earn a place on the Top Workplaces USA list based solely on employee engagement surveys compiled by research firm Energage.

Global Protein Expression Market Research Report 2021 Featuring Major Players - Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific, New England Biolabs and Promega - ResearchAndMarkets.com

Retrieved on: 
星期二, 一月 25, 2022
Biotechnology, FDA, Health, Pharmaceutical, Clinical Trials, COVID-19, Hormone, Therapy, Center, World, China Biologic Products, Jonathan Rothberg, Gene, Industry, Conditional sentence, Marketing, Patient, Center for Drug Evaluation and Research, Chemistry World, Insulin, Transport, FDA, Allergen, Blood, 101, Microfluidics, Medicine, Research, Cancer, CDER, Thermo Fisher Scientific, Cell, Prevalence, TOC, Bio-Rad Laboratories, Clinical trial, Food, Protein expression, European Medicines Agency, CFR, Technology, Time, World Health Organization, Antibody, Pharmacology, New England Biolabs, Promega, Antigen, Agilent Technologies, Safety, Food and Drug Administration, Health, Growth, Policy, Lists of diseases, Vaccine, Protein, Dietary supplement, Pharmaceutical industry, Sphere

Major players in the protein expression market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., New England Biolabs and Promega Corporation.

Key Points: 
  • Major players in the protein expression market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., New England Biolabs and Promega Corporation.
  • The protein expression market consists of sales of protein expression vectors, competent cells, reagents, equipment and related services.
  • Protein expression included yeast expression, insect expression, and bacterial expression, algal expression and mammalian cell expression.
  • The protein expression market covered in this report is segmented by protein expression into yeast expression, mammalian expression, algae expression, insect expression, bacterial expression, cell-free expression.

Bacterial and Plasmid Vectors Global Market Report 2021 Featuring Sigma-Aldrich, ATUM, QIAGEN, Promega, Thermo Fisher Scientific, GenScript Biotech, Takara Bio, IBA, Bio-Rad Labs, New England Biolabs - ResearchAndMarkets.com

Retrieved on: 
星期三, 十二月 8, 2021
Health, Biotechnology, Genetics, Bacteria, Eye, Biotechnology, Climate change, Segment, Promega, Growth, Infection, Prevalence, Food, Death, Retina, DNA, World Health Organization, Organization, Bio-Rad Laboratories, IBA, Cancer, Genetic engineering, IRDS, Government, A-DNA, Molecular biology, COVID-19, Criticism of the Food and Drug Administration, Public health, World, ATUM, Application, Plasmid, QIAGEN, WHO, Vaccine

Major players in the bacterial & plasmid vectors market are Sigma-Aldrich Inc., ATUM, QIAGEN, Promega Corporation, Thermo Fisher Scientific, Inc., GenScript Biotech Corporation, Takara Bio Inc., IBA GmbH, Bio-Rad Laboratories, and New England Biolabs.

Key Points: 
  • Major players in the bacterial & plasmid vectors market are Sigma-Aldrich Inc., ATUM, QIAGEN, Promega Corporation, Thermo Fisher Scientific, Inc., GenScript Biotech Corporation, Takara Bio Inc., IBA GmbH, Bio-Rad Laboratories, and New England Biolabs.
  • The bacterial & plasmid vectors market consists of sales of bacterial & plasmid vectors and related services by entities (organizations, sole traders and partnerships) that develop bacterial and plasmid vectors for biotechnological applications.
  • The bacterial & plasmid vectors market covered in this report is segmented by host type into E.coli expression vectors, other bacterial expression vectors and by application into genetics, molecular biology, bioinformatics, others.
  • Therefore, the growing prevalence of cancer and various infectious diseases and surging demand for bacterial & plasmid vectors for gene therapy is projected to propel the market revenues for bacterial & plasmid vectors' market.

Promega Launches Sanger Sequencing Chemistry Compatible With All Capillary Electrophoresis Platforms

Retrieved on: 
星期二, 十月 19, 2021
Research, Genetics, Clinical Trials, Biotechnology, Health, Pharmaceutical, Other Science, Science, Oncology, Government, Promega, Terminator, Cell biology, SR, Protein sequencing, Drug development, RNA, Multimedia, Sanger, CE, Thermo Fisher Scientific, Industry, DNA, NGS, Medical device, Optical instrument

Research labs performing Sanger sequencing can now use Promega chemistry on any capillary electrophoresis (CE) platform.

Key Points: 
  • Research labs performing Sanger sequencing can now use Promega chemistry on any capillary electrophoresis (CE) platform.
  • View the full release here: https://www.businesswire.com/news/home/20211019005182/en/
    More than 40 years after its invention, Sanger sequencing remains the gold standard for DNA sequencing.
  • It is often used for mitochondrial sequencing and de novo sequencing, or to confirm results from next-generation sequencing (NGS).
  • Even as NGS becomes less expensive, Sanger sequencing remains the most cost-efficient method for sequencing shorter pieces of DNA.

Single-cell Analysis Markets, 2026 - High Growth Potential of Single-cell Sequencing & Integration of Microfluidics in Single-cell Analysis - ResearchAndMarkets.com

Retrieved on: 
星期二, 十月 12, 2021
Health, Biotechnology, Growth, USD, Merck Millipore, Genomics, CAGR, Flow cytometry, Promega, Microscopy, Danaher Corporation, Corning Inc., QIAGEN, Cancer, Cell type, Research, Illumina, Inc., Prevalence, Laboratory, Consumables, Becton, Dickinson and Company headquarters, Human, RNA, Becton, Single-cell analysis, DNA, PCR, NGS, Fine chemical

The global single-cell analysis market is projected to reach USD 6.3 billion by 2026 from USD 3.1 billion in 2021, at a CAGR of 15.1% during the forecast period.

Key Points: 
  • The global single-cell analysis market is projected to reach USD 6.3 billion by 2026 from USD 3.1 billion in 2021, at a CAGR of 15.1% during the forecast period.
  • On the other hand, the high cost of single-cell analysis instruments is expected to hinder market growth to a certain extent.
  • The consumables segment accounted for the highest growth rate in the single-cell analysis market, by product, during the forecast period
    Consumables accounted for the largest share of 67.4% of the single-cell analysis market in 2020.
  • The human cells segment accounted for the largest share of 51.6% of the single-cell analysis market in 2020.

Global Real Time PCR Market Research Report 2021 - ResearchAndMarkets.com

Retrieved on: 
星期五, 十月 8, 2021
Software, Biotechnology, Oncology, Health, Medical Devices, Infectious Diseases, Technology, Genetics, Company, Real-time, Infection, Abbott Laboratories, Real-time polymerase chain reaction, Thermo Fisher Scientific, Promega, Software, Danaher Corporation, Diagnosis, Cancer, Growth, Ortho Clinical Diagnostics, Reagent, Prevalence, Agilent Technologies, Lists of diseases, Becton, Dickinson and Company headquarters, Gene expression, Gene, DNA, PCR, Government, Medical device, Vaccine

The "Global Real Time PCR Market, By Product (Reagents & Consumables, Instruments, Software & Services), By Application (Clinical Diagnostics, Research, Forensic), By End-User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Real Time PCR Market, By Product (Reagents & Consumables, Instruments, Software & Services), By Application (Clinical Diagnostics, Research, Forensic), By End-User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.
  • Additionally, government and health organizations across the globe are also introducing funds and grants for the development of new PCR technologies, which is further fuelling the growth of the Global Real Time PCR Market.
  • The Global Real Time PCR Market is segmented based on product, application, end-user and company, region.
  • Based on region, North America dominates the Global Real Time PCR Market owing to the increased funding for genomic research and increasing use of PCR techniques for clinical diagnostics and forensic.

Applications of Bioluminescent Research Tools Showcased at Global Seminar Series

Retrieved on: 
星期二, 八月 24, 2021
Other Health, Research, General Health, Pharmaceutical, Oncology, Medical Devices, Genetics, Science, Biotechnology, Medical Supplies, Other Science, Health, Industry, University of Dundee, University, Structural biology, City, Apple Advanced Technology Group, Cell biology, Method, GLO, Promega, Research, DNA, Government, RNA, G protein-coupled receptor, Multimedia, CEO, COVID-19, Technology, Drug development, Pharmaceutical industry, Fine chemical

Life science and drug discovery researchers interested in bioluminescent tools will have the opportunity to hear from global thought leaders on the possibilities and applications of luciferase technologies during the upcoming Discover Glo 2021 virtual seminar series.

Key Points: 
  • Life science and drug discovery researchers interested in bioluminescent tools will have the opportunity to hear from global thought leaders on the possibilities and applications of luciferase technologies during the upcoming Discover Glo 2021 virtual seminar series.
  • Hosted by Promega and held September 13-16, the series will advance understanding in important therapeutic areas such as Targeted Protein Degradation and Kinase Biology.
  • View the full release here: https://www.businesswire.com/news/home/20210824005122/en/
    The possibilities and applications of luciferase technologies will be the focus of the upcoming Discover Glo 2021 virtual seminar series hosted by Promega Corporation September 13-16.
  • (Photo: Business Wire)
    Over the last three decades, assays and technologies utilizing the natural phenomenon of bioluminescence have gone from novel research tools to foundational elements of the modern research toolbox.

Wastewater Testing Labs Can Detect SARS-CoV-2 in Less Than Four Hours with New Methods

Retrieved on: 
星期一, 八月 16, 2021
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Medical Devices, Genetics, Method, Science of the Total Environment, Multimedia, Cell biology, NGS, Infection, Wastewater, RNA, Government, Drug development, COVID-19, Total, DNA, Research, Virus, Health, Severe acute respiratory syndrome coronavirus 2, Promega, Workflow, Industry, Feces, Vaccine, Fine chemical

As a result, the levels of SARS-CoV-2 RNA in wastewater reflect the trends in infection rates in a given community.

Key Points: 
  • As a result, the levels of SARS-CoV-2 RNA in wastewater reflect the trends in infection rates in a given community.
  • These methods overcome the shortcomings of traditional precipitation-based isolation of viral particles, which fail to capture the degraded viruses present in wastewater.
  • Both kits are designed to work with the large sample volumes required for wastewater testing and remove inhibitors that can disrupt downstream testing.
  • The purification kits can be used with the SARS-CoV-2 RT-qPCR Kit for Wastewater to form a complete workflow for monitoring SARS-CoV-2 levels in wastewater.